Skip to main content

Table 2 Wilcoxon sign-rank test was used to test the difference between pre-PP1M and Post-PP1M

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

 

Medicine costs

Hospitalization costs

Direct costs

pre-PP1M (¥)

8302 ± 4156

9155 ± 18816

17457 ± 17414

Post-PP1M (¥)

20121 ± 4580

2915 ± 8466

23030 ± 8648

Difference

142%

-68.15%

31.92%

P

< 0.01

0.074

< 0.01